Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.For More Videos, please see below:Lymphoma Cancer Treatment NY – Weill Cornell


Dr. Richard R. Furman, MD
0
The iMedixStars rating goes beyond a simple average of reviews. It’s calculated based on various factors, including the quantity, recency, and reliability of the reviews. Read More
Overwiew
Doctor Organizations
- Newyork Presbyterian Columbia University Irving Medical Center
Doctor Education
Medical School
1993
Icahn School Of Medicine At Mount Sinai
Work Place
Chronic Lymphocytic Leukemia (CLL)
520 East 70th Street Starr Pavilion, 3rd Floor
New York
NY
10021
USA
(800) 419-1109
https://weillcornell.org/rrfurman
Specialties
- Internal Medicine
- Oncologist
- Hematologist
Procedures performed
- Chemotherapy
- Blood transfusion
- Chemotherapy
Conditions
- Anemia
- Leukemia
- Multiple Myeloma
- Hodgkin's Lymphoma
- Iron Deficiency Anemia
- Non-Hodgkin's Lymphoma
- Reviews
- Q&A
0 total
- 5 0 %
- 4 0 %
- 3 0 %
- 2 0 %
- 1 0 %
There are no questions!
Leave a comment